Radiopharm Theranostics (RADX) Other Non-Current Assets (2024)
Radiopharm Theranostics (RADX) reported Other Non-Current Assets of $263.61 for Q2 2024.
Radiopharm Theranostics (RADX) Other Non-Current Assets (2024) Analysis & Trends
Radiopharm Theranostics (RADX) has 1 years of Other Non-Current Assets data on file, last reported at $263.61 in Q2 2024.
- Other Non-Current Assets for Q2 2024 came in at $263.61, changed N/A year-over-year; the trailing twelve-month figure through Jun 2024 was $263.61 (changed N/A YoY), and the FY2024 annual result was $40000.0, changed N/A from the prior year.
- Other Non-Current Assets was little changed at $263.61 in Q2 2024 per RADX's latest filing.
- Over five years, Other Non-Current Assets peaked at $263.61 in Q2 2024 and troughed at $263.61 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Radiopharm Theranostics | 5.82 Bn | 5.81 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 263.61 |